Publication
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
Journal Paper/Review - Jun 1, 2018
Weyerbrock Astrid
Units
Contact
Citation
Weyerbrock A. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro Oncol 2018; 2018 Jun
Type
Journal Paper/Review (English)
Journal
Neuro Oncol 2018; 2018 Jun
Publication Date
Jun 1, 2018